IWM
OPNT

IHT Wealth Management’s Opiant Pharmaceuticals, Inc. Common Stock OPNT Stock Holding History

IHT Wealth Management’s Portfolio OPNT Stock Details OPNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-271
Closed -$5K – 1465
2018
Q1 		$5K Hold
271
– – ﹤0.01% 1356
2017
Q4 		$7K Buy
+271
New +$8.68K ﹤0.01% 1279

Other funds holding OPNT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $20.1B AUM 30.42% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
LTFS
Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

IHT Wealth Management's OPNT Position: Q2 2018 in Review

IHT Wealth Management sold out of Opiant Pharmaceuticals, Inc. Common Stock (OPNT) in Q2 2018, closing a stake of 271 shares — an estimated $5K sold.

IHT Wealth Management first reported a position in OPNT in Q4 2017 and held it in 2 quarters. The position peaked at $7K in Q4 2017. 16 funds tracked by Wall St. Rank hold OPNT as of Q2 2018.

  • IHT Wealth Management reported no remaining Opiant Pharmaceuticals, Inc. Common Stock position as of Q2 2018 after selling out during the quarter.
  • IHT Wealth Management sold 271 Opiant Pharmaceuticals, Inc. Common Stock shares in Q2 2018, an estimated $5K.
  • IHT Wealth Management first reported a position in Opiant Pharmaceuticals, Inc. Common Stock in Q4 2017 and held it in 2 quarters.
  • IHT Wealth Management's Opiant Pharmaceuticals, Inc. Common Stock position peaked at $7K in Q4 2017.
  • 16 funds tracked by Wall St. Rank held Opiant Pharmaceuticals, Inc. Common Stock as of Q2 2018.

Based on IHT Wealth Management's 13F filing for Q2 2018, filed 13 Aug 2018.